relating to method

See: procedural
Mentioned in ?
References in periodicals archive ?
The first amended agreement provides Genprex with an option to exclusively license patent applications and related intellectual property relating to methods of treating cancer by combining TUSC2 with any of the immune checkpoint inhibitors known to stimulate immune responses, including but not limited to nivolumab (Opdivo), pembrolizumab (Keytruda), ipilimumab (Yervoy), and anti-KIR antibodies such as lirilumab.
"With these amended agreements in place, we will continue to advance and expand our clinical development program with Oncoprex for the treatment of non-small cell lung cancer and other potential therapeutic targets." The first amended agreement provides Genprex with an option to exclusively license patent applications and related intellectual property relating to methods of treating cancer by combining TUSC2 with any of the immune checkpoint inhibitors known to stimulate immune responses, including but not limited to nivolumab, pembrolizumab, ipilimumab, and anti-KIR antibodies such as lirilumab.The second amended agreement provides Genprex with an option to exclusively license an issued U.S.
The technology relates to methods of decomposing a gaseous medium most specifically relating to methods of utilizing radio frequency energy to separate the elemental components of gases such as carbon dioxide.
"The Conference has provided a platform for brainstorming and discussions on matters relating to methods of recruitment, personnel policies, conduct of examination, etc," he said.
(1) Directive 73/404/EEC on the approximation of the laws of member states relating to detergents; Directive 73/405/EEC on the approximation of the law of the member states relating to methods of testing the biodegradability of anionic surfactants; Regulation (EC) 648/2004 of the European Parliament and the Council of March 31, 2004 with regard to detergents
The United States Patent and Trademark Office has issued the University of Utah (Salt Lake City, UT) United States Patent 6,569,627 ("the '627 patent ") relating to methods of nucleic acid amplification in the presence of certain dyes such as SYBR Green I.
26 June 2014 - Israeli microRNA-based molecular diagnostics developer Rosetta Genomics Ltd (NASDAQ:ROSG) said Thursday it had received a notice of allowance for a US patent protecting the expression of miR-205 as an indicator of good prognosis, and relating to methods and kits for prognosis of prostate cancer.